Opinion
7hon MSNOpinion
Pfizer Just Raised Its 2026 Guidance -- but the Boost Leans Heavily on a Drug Running Out the Patent Clock
This problem has a solution, and Pfizer is implementing it.
Pfizer is a highly respected drug company facing normal industry headwinds.
New York City is counting on office-to-apartment conversions to help relieve its housing shortage. But after structural ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results